AHR and hepatocellular carcinoma: Using Hepa.2DLuc cells, a mouse hepatoma cell line stably transfected with the AhR reporter plasmid p2Dluc [27], [28], we determined that there was no significant change in DRE-mediated transcription (Figure 2A), indicating that CH-223191 does not exhibit any agonist activity [37].